01. Doctor Overview
A board-certified surgeon, Dr. Kiran Turaga holds several positions at the University of Chicago Medicine Comprehensive Cancer Center. He serves as the Vice Chief, Section of General Surgery and Surgical Oncology. He is also the director of the Surgical Gastrointestinal Cancer Program and the Regional Therapeutics Program. Dr. Turaga is also a professor of surgery at the University of Chicago Medicine Comprehensive Cancer Center. As a graduate of All India Institute of Medical Sciences, Dr. Turaga completed his internship and residency at Creighton University Medical Center. He completed his fellowships at Moffitt Cancer Center and the University of Pittsburgh Medical Center.
Dr. Turaga is a surgical oncologist with a special interest in the treatment of advanced malignancies, including metastatic cancers. He is an expert in heated intraperitoneal chemotherapy (HIPEC) which is a heated chemotherapy wash administered to the abdominal cavity after surgery to remove tumors and lesions. He treats a wide range of abdominal and peritoneal diseases, including colon cancer, appendix cancer, mesothelioma and malignant bowel obstructions.
Dr. Turaga is a clinical researcher with a focus on the development of novel diagnostics and therapeutics for oligometastatic cancer including mesothelioma. He is also interested in studying how big data systems can be used to provide the most optimal, cost-effective patient care.
In addition to Dr. Turaga’s clinical work, he is an influential researcher who has published more than 100 peer-reviewed articles. He is an international authority on peritoneal surface disease. Some of the medical journals he has been published in include Annals of Surgical Oncology, British Journal of Cancer and Journal of Oncology Practice. Peritoneal mesothelioma is explored in several of his publications.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Gastrointestinal Surgery
Other Interests & Specialties: Heated intraperitoneal chemotherapy (HIPEC), general surgery, surgical oncology, mesothelioma, peritoneal disease, appendix cancer, colon cancer, desmoplastic small round cell tumors, locally advanced complex malignancies, malignant melanoma, malignant bowel obstruction, minimally invasive surgery, retroperitoneal sarcomas and metastatic malignancies.
Certifications, Awards & Accolades: American Board of Surgery Certification in General Surgery, Sharon Wadina Endowed Professor of Sarcoma Research, Lee Biblo Award for Professional Excellence, Bucksbaum Senior Faculty Scholar for Clinical Excellence in 2018, Distinguished Faculty in Program Innovation Award in 2019, member of the Mesothelioma Research Foundation Scientific Advisory Board
Education & Experience:
- Medical Degree from All India Institute of Medical Sciences
- Internship at Creighton University Medical Center
- Residency at Creighton University Medical Center
- Fellowship at Moffitt Cancer Center
- Fellowship at University of Pittsburgh Medical Center
Current management strategies for peritoneal mesothelioma. International Journal of Hyperthermia. March 2017;33(5):579-581. doi: 10.1080/02656736.2017.1320591
Current Trends in the Management of Malignant Peritoneal Mesothelioma. Annals of Surgical Oncology. May 2014;21(12):3947-3953. doi: 10.1245/s10434-014-3803-6
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis. Annals of Surgical Oncology. May 2015;22(5):1686-1693. doi: 10.1245/s10434-014-3978-x
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. Journal of Clinical Oncology. August 2018;36(28):2863-2871. doi: 10.1200/JCO.2018.78.5204
Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. British Journal of Cancer. February 2021;124(3):564-566. doi: 10.1038/s41416-020-01130-x
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. Journal of Oncology Practice. October 2016;12(10):928-935. doi: 10.1200/JOP.2016.011908